Making a meaningful difference

Turning scientific innovation into meaningful impact

Zymeworks is a royalty-driven organization differentiated by in-house R&D capabilities developing novel medicines for patients with difficult-to-treat diseases. Through our proprietary platforms, deep scientific expertise, and global partnerships, we build and manage a portfolio of healthcare assets designed to deliver long-term impact across multiple therapeutic indications.

Partner with us

Integrating partnerships and collaborations is core to our business strategy and allows us to accelerate our efforts to bring novel therapeutics to the broadest group of patients.

News

April 9, 2026

Zymeworks to Present at the AACR Oncology Industry Partnering Event

April 9, 2026

Zymeworks Announces Additional Leadership Appointments to Advance Next Phase of Growth

April 1, 2026

Zymeworks Appoints Kristin Stafford as Chief Financial Officer